"Molecular Susceptibility and Treatment Challenges in Melanoma" by Kiran Kumar Kolathur, Radhakanta Nag et al.
 

Molecular Susceptibility and Treatment Challenges in Melanoma

Document Type

Article

Publication Title

Cells

Abstract

Melanoma is the most aggressive subtype of cancer, with a higher propensity to spread compared to most solid tumors. The application of OMICS approaches has revolutionized the field of melanoma research by providing comprehensive insights into the molecular alterations and biological processes underlying melanoma development and progression. This review aims to offer an overview of melanoma biology, covering its transition from primary to malignant melanoma, as well as the key genes and pathways involved in the initiation and progression of this disease. Utilizing online databases, we extensively explored the general expression profile of genes, identified the most frequently altered genes and gene mutations, and examined genetic alterations responsible for drug resistance. Additionally, we studied the mechanisms responsible for immune checkpoint inhibitor resistance in melanoma.

DOI

10.3390/cells13161383

Publication Date

8-1-2024

This document is currently not available here.

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 2
  • Usage
    • Abstract Views: 1
  • Captures
    • Readers: 7
  • Mentions
    • News Mentions: 1
see details

Share

COinS